New Zealand
Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries
Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...
December 19, 2023 | News
MGI Australia Introduces Innovative CEC with DCS Lab Products for Advanced DNA, Cell, and Spatial-omics Technology
MGI Australia, a subsidiary of MGI Tech Co. Ltd. (MGI), a global leader in life science technology, is delighted to announce a substantial expans...
December 15, 2023 | News
Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio
First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...
October 13, 2023 | News
EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand
EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...
October 12, 2023 | News
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy
ST to partner with Dutch biotech company Treeway BV First CNS therapy in ST therapeutic portfolio The therapy is known as TW001 and is a un...
August 28, 2023 | News
First Patient Dosed in TLX101 Brain Cancer Study for Newly Diagnosed Glioblastoma
IPAX-2 (ClinicalTrials.gov Identifier: NCT05450744) is a Phase I dose escalation study to confirm safety profile of TLX101 in combination with externa...
August 08, 2023 | News
Doer Biologics Initiates Phase I MAD Trial of DR10624, Receives NMPA IND Approval
The Phase I MAD study is a randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics ...
August 02, 2023 | News
Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...
July 17, 2023 | News
Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...
June 01, 2023 | News
Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand
Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...
May 31, 2023 | News
Leading New Zealand Cancer Research Gets a Data Privacy Boost with Amaroq Therapeutics and GeneCrypt Partnership
Amaroq Therapeutics, a world-leading company based in New Zealand focused on developing a new class of therapeutics that targets long non-coding ...
May 26, 2023 | News
Formus Labs Receives FDA Clearance for AI-Powered Orthopedic Surgery Planning Technology.
Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as th...
May 04, 2023 | News
Why Pharma and Medtech manufacturers are striving for digital maturity
Why pharma and medtech manufacturers are striving for...
April 25, 2023 | News
Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics
The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...
April 12, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
